LabArchives Integrates with Microsoft Office Online to Increase Workflow Productivity
May 10, 2017
LabArchives integration with Microsoft Office Online provides principal investigators, instructors, and students around the world with an improved integrated user experience. Carlsbad, California LabArchives, a leading cloud-based Electronic Lab Notebook (ELN) in higher education research and instruction, announced today an integration with Microsoft Office Online to provide principal investigators, instructors, and students around the world [...]
NanoString Appoints Elisha W. Finney to Board of Directors
May 10, 2017
SEATTLE -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the appointment of Elisha W. Finney, former executive vice president and chief financial officer at Varian Medical Systems (NYSE: VAR), to its Board of Directors and Audit Committee. Ms. Finney brings more than 25 years of financial and life [...]
May 10, 2017
CINCINNATI -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced it will commence a global search for a new Chief Executive Officer in conjunction with the planned retirement of John A. Kraeutler in accordance with the terms of his employment agreement. Mr. Kraeutler plans to continue to serve in the capacity of CEO until his successor is found. Going forward he [...]
MilliporeSigma Acquires Grzybowski Scientific Inventions to Expand Chemical Synthesis Offering
May 9, 2017
- Revolutionary computer-aided retro-synthesis software optimizes productivity, organic synthesis - Complements MilliporeSigma's leading e-commerce platform and chemistry portfolio of more than 400,000 building blocks, catalysts and reagents for chemical synthesis This image illustrates the synthetic pathways a researcher using Chematica might be given. Each burst represents the viable reaction options. The connections between the bursts [...]
Edico Genome Raises $22 Million in Series B Financing
May 9, 2017
New investor Dell Technologies Capital leads round; all existing investors participate SAN DIEGO – Edico Genome announced today it has raised $22 million in a Series B financing to expand market adoption and product development of its DRAGEN™ platform, an end-to-end solution for analysis of next-generation sequencing data. New investor Dell Technologies Capital, the venture arm [...]
May 9, 2017
Ortenberg, Germany – The MetaCell-TM project H2020 Fast Track to Innovation (FTI) €2.5m funding enables the consortium of BMG LABTECH GmbH, Luxcel Biosciences Ltd and Axiogenesis AG to develop a physiologically relevant cell-based assay platform for metabolism in preclinical drug discovery and development. This project is supported by two highly respected research institutions, Oxford University, [...]
New Syngene G:BOX imaging systems with HI-LED lighting
May 9, 2017
Cambridge, UK: Syngene, a world-leading manufacturer of image analysis solutions, is delighted to announce its latest options for its highly successful G:BOX automated multi-purpose gel and blot imaging systems are now available. Utilising high intensity, “HI-LED” lighting and updated image capture software, these flexible systems guarantee cost-effective imaging and faster workflow with a huge range [...]
May 9, 2017
Leading Big Data company developing platform with clinical and genomic data from 5 million subjects, to transform drug development and bring clinical benefits to patients. BC Platforms, a world leader in genomic data management solutions, today announces that it has closed a $USD 10 million financing round. The round was led by Debiopharm Innovation Fund in conjunction [...]
May 9, 2017
Licensing agreement will support Oxford Genetics growing bio-therapeutic discovery, development and manufacturing service business. Oxford – Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery and development, today announces it has signed a non-exclusive licensing agreement with ERS Genomics to access its foundational intellectual property related to CRISPR/Cas9 gene editing technology. [...]
Muse bio appoints genomics industry expert, John Stuelpnagel, as Chairman of the Board of Directors
May 9, 2017
Boulder, CO – Muse bio, a privately-held company leading the development of next-generation genome engineering capabilities, today announced Dr. John Stuelpnagel, co-founder, first CEO and former COO of Illumina and a well-known genomics industry entrepreneur, will become Chairman of Muse bio’s Board of Directors. In addition to Illumina, Dr. Stuelpnagel has co-founded and held senior [...]

